Journal of the American Academy of Dermatology
Volume 59, Issue 5 , Pages 822-833 , November 2008

The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease

  • Cynthia M. Magro, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Cynthia M. Magro, MD, Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, 1300 York Ave, F-309, New York, NY 10065.
    • ,
  • Molly E. Dyrsen, MD

References 

  1. Magro CM, Crowson AN. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol. 1997;24:543–552
  2. Magro CM, Crowson AN, Regauer S. Mixed connective tissue disease: a clinical, histologic, and immunofluorescence study of eight cases. Am J Dermatopathol. 1997;19:206–213
  3. Magro CM, Crowson AN, Harrist TJ. The use of antibody to C5b-9 in the subclassification of lupus erythematosus. Br J Dermatol. 1996;134:855–862
  4. Vasil KE, Magro CM. Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda. J Am Acad Dermatol. 2007;56:96–104
  5. George R, Kurian S, Jacob M, Thomas K. Diagnostic evaluation of the lupus band test in discoid and systemic lupus erythematosus. Int J Dermatol. 1995;34:170–173
  6. Harrist TJ, Mihm MC. Cutaneous immunopathology: the diagnostic use of direct and indirect immunofluorescence techniques in dermatologic disease. Hum Pathol. 1979;10:625–653
  7. Barnadas MA, Perez E, Gich I, Llobet JM, Ballarin J, Calero F, et al. Diagnostic, prognostic and pathogenic value of the direct immunofluorescence test in cutaneous leukocytoclastic vasculitis. Int J Dermatol. 2004;43:19–26
  8. Yamashina M, Takami T, Kanemura T, Orii T, Ojima A. Immunohistochemical demonstration of complement components in formalin-fixed and paraffin-embedded renal tissues. Lab Invest. 1989;60:311–316
  9. Fogazzi GB, Bajetta M, Banfi G, Mihatsch M. Comparison of immunofluorescent findings in kidney after snap-freezing and formalin fixation. Pathol Res Pract. 1989;185:225–230
  10. Sinclair RA, Burns J, Dunnill MS. Immunoperoxidase staining of formalin-fixed, paraffin-embedded, human renal biopsies with a comparison of the peroxidase-antiperoxidase (PAP) and indirect methods. J Clin Pathol. 1981;34:859–865
  11. Nasr SH, Galgano SJ, Markowitz GS, Stokes MB, D'Agati VD. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies. Kidney Int. 2006;70:2148–2151
  12. Rodriguez ER, Skojec DV, Tan CD, Zachary AA, Kasper EK, Conte JV, et al. Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant. 2005;5:2778–2785
  13. Haas M, Rahman MH, Racusen LC, Kraus ES, Bagnasco SM, Segev DL, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant. 2006;6:1829–1840
  14. Troxell ML, Weintraub LA, Higgins JP, Kambham N. Comparison of C4d immunostaining methods in renal allograft biopsies. Clin J Am Soc Nephrol. 2006;1:583–591
  15. Magro CM, Pope Harman A, Klinger D, Orosz C, Adams P, Waldman J, et al. Use of C4d as a diagnostic adjunct in lung allograft biopsies. Am J Transplant. 2003;3:1143–1154
  16. Miller GG, Destarac L, Zeevi A, Girnita A, McCurry K, Iacono A, et al. Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid. Am J Transplant. 2004;4:1323–1330
  17. Herman J, Lerut E, Van Damme-Lombaerts R, Emonds MP, Van Damme B. Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies. Transplantation. 2005;79:1435–1440
  18. Kuypers DR, Lerut E, Evenepoel P, Maes B, Vanrenterghem Y, Van Damme B. C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome. Transplantation. 2003;76:102–108
  19. Magro CM, Abbas AE, Seilstad K, Pope-Harman AL, Nadasdy T, Ross P. C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction. Hum Immunol. 2006;67:274–283
  20. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26:1229–1242
  21. Jianghua C, Wenqing X, Huiping W, Juan J, Jianyong W, Qiang H. C4d as a significant predictor for humoral rejection in renal allografts. Clin Transplant. 2005;19:785–791
  22. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmüller G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int. 1993;43:1333–1338
  23. Vallhonrat H, Williams WW, Cosimi AB, Tolkoff-Rubin N, Ginns LC, Wain JC, et al. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients. Transplantation. 1999;67:253–258
  24. Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Williams WW, Tolkoff-Rubin N, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol. 1999;10:2208–2214
  25. Platt JL. C4d and the fate of organ allografts. [review] J Am Soc Nephrol. 2002;13:2417–2419
  26. Watschinger B, Pascual M. Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection. [review] J Am Soc Nephrol. 2002;13:2420–2423
  27. Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol. 2001;12:574–582
  28. Haas M, Ratner LE, Montgomery RA. C4d staining of perioperative renal transplant biopsies. Transplantation. 2002;74:711–717
  29. Ranjan P, Nada R, Jha V, Sakhuja V, Joshi K. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction. Nephrol Dial Transplant. 2008;23:1735–1741
  30. Al-Aly Z, Reddivari V, Moiz A, Balasubramanian G, Cortese CM, Salinas-Madrigal L, et al. Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system. Transpl Int. 2008;21:268–275
  31. Mroz A, Lewandowski Z, Cieciura T, Matłosz B, Pazik J, Kwiatkowski A, et al. C4d complement split product in diagnosis of immunological activity of chronic allograft nephropathy. Transplant Proc. 2006;38:97–100
  32. Baldwin WM, Samaniego-Picota M, Kasper EK, Clark AM, Czader M, Rohde C, et al. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation. 1999;68:894–900
  33. Eggertsen G, Nyberg G, Nilsson B, Nilsson U, Svalander CT. Complement deposition in renal allografts with early malfunction. APMIS. 2001;109:825–834
  34. Kanitakis J, McGregor B, Badet L, Petruzzo P, Morelon E, Devauchelle B, et al. Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study. Transplantation. 2007;84:265–267
  35. Schrager MA, Rothfield NF. Pathways of complement activation in chronic discoid lupus: serologic and immunofluorescence studies. Arthritis Rheum. 1977;20:637–645
  36. Smith CD, Marino C, Rothfield NF. The clinical utility of the lupus band test. Arthritis Rheum. 1984;27:382–387
  37. Magro CM, Dyrsen M, Kerns MJ. Cutaneous lesions of dermatomyositis with supervening fibrosis. J Cutan Pathol. 2008;35:31–39
  38. Torinuki W, Miura T, Tagami H. Activation of complement by 405-nm light in serum from porphyria cutanea tarda. Arch Dermatol Res. 1985;277:174–178
  39. Zwirner J, Burg M, Schulze M, Brunkhorst R, Götze O, Koch KM, et al. Activated complement C3: a potentially novel predictor of progressive IgA nephropathy. Kidney Int. 1997;51:1257–1264
  40. Helm TN, Valenzuela R, Glanz S, Parker L, Dijkstra J, Bergfeld WF. Relapsing polychondritis: a case diagnosed by direct immunofluorescence and coexisting with pseudocyst of the auricle. J Am Acad Dermatol. 1992;26:315–318
  41. Ebringer R, Rook G, Swana GT, Bottazzo GF, Doniach D. Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases. Ann Rheum Dis. 1981;40:473–479
  42. Moore FM, White SD, Carpenter JL, Torchon E. Localization of immunoglobulins and complement by the peroxidase antiperoxidase method in autoimmune and non-autoimmune canine dermatopathies. Vet Immunol Immunopathol. 1987;14:1–9
  43. Haines DM, Cooke EM, Clark EG. Avidin-biotin-peroxidase complex immunohistochemistry to detect immunoglobulin in formalin fixed skin biopsies in canine autoimmune skin disease. Can J Vet Res. 1987;51:104–109
  44. Roebker JJ, Case JD, Lear SC, Hodge SJ, Callen JP. Immunoperoxidase technique on paraffin sections fails to demonstrate immunoglobulin deposition in cutaneous lesions from patients with dermatomyositis. Am J Dermatopathol. 1988;10:297–299

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(08)00747-0

doi: 10.1016/j.jaad.2008.06.022

Journal of the American Academy of Dermatology
Volume 59, Issue 5 , Pages 822-833 , November 2008

Article Tools

* Image Usage & Resolution